Skip to main content
. Author manuscript; available in PMC: 2017 Apr 28.
Published in final edited form as: Circulation. 2013 Dec 18;129(3):e28–e292. doi: 10.1161/01.cir.0000441139.02102.80

Table 20-1.

Pooled Prevalence of Valvular Heart Disease From CARDIA, ARIC, and CHS Cohorts

Age, y
P Value for Trend Frequency Adjusted to 2000 US Adult Population
18–44 45–54 55–64 65–74 ≥75
Participants, n 4351 696 1240 3879 1745 209 128 094
Male 1959 (45) 258 (37) 415 (33) 1586 (41) 826 (47) 100 994 367 (48)
Mitral regurgitation (n=449) 23 (0.5) 1 (0.1) 12 (1.0) 250 (6.4) 163 (9.3) <0.0001 1.7% (95% CI, 1.5%–1.9%)
Mitral stenosis (n=15) 0 (0) 1 (0.1) 3 (0.2) 7 (0.2) 4 (0.2) 0.006 0.1% (95% CI, 0.02%–0.2%)
Aortic regurgitation (n=90) 10 (0.2) 1 (0.1) 8 (0.7) 37 (1.0) 34 (2.0) <0.0001 0.5% (95% CI, 0.3%–0.6%)
Aortic stenosis (n=102) 1 (0.02) 1 (0.1) 2 (0.2) 50 (1.3) 48 (2.8) <0.0001 0.4% (95% CI, 0.3%–0.5%)
Any valve disease
 Overall (n=615) 31 (0.7) 3 (0.4) 23 (1.9) 328 (8.5) 230 (13.2) <0.0001 2.5% (95% CI, 2.2%–2.7%)
 Women (n=356) 19 (0.8) 1 (0.2) 13 (1.6) 208 (9.1) 115 (12.6) <0.0001 2.4% (95% CI, 2.1%–2.8%)
 Men (n=259) 12 (0.6) 2 (0.8) 10 (2.4) 120 (7.6) 115 (14.0) <0.0001 2.5% (95% CI, 2.1%–2.9%)

Values are n (%) unless otherwise indicated.

ARIC indicates Atherosclerosis Risk in Communities study; CARDIA, Coronary Artery Risk Development in Young Adults; CHS, Cardiovascular Health Study; CI, confidence interval; and ellipses (…), not applicable.

Source: Reprinted from The Lancet, Nkomo et al1 with permission from Elsevier. Copyright © 2006, Elsevier Ltd.